Ruxolitinib versus best available therapy in patients with...

Haematologica 2016 / 07 Vol. 101; Iss. 7

Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial

Verstovsek, S., Vannucchi, A. M., Griesshammer, M., Masszi, T., Durrant, S., Passamonti, F., Harrison, C. N., Pane, F., Zachee, P., Kirito, K., Besses, C., Hino, M., Moiraghi, B., Miller, C. B., Cazzo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
101
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2016.143644
Date:
July, 2016
File:
PDF, 1.30 MB
english, 2016
Conversion to is in progress
Conversion to is failed